Yemaachi is a biotechnology company dedicated to improving health outcomes by diversifying genomic data, with a focus on African populations. It develops and sells diagnostic test kits and offers advanced genomic testing services directly to consumers and healthcare providers. The company also engages in strategic partnerships with global pharmaceutical firms for large-scale research in areas like cancer genomics and vaccine development.
| Customer | Success Story | Source |
|---|---|---|
| Yemaachi launched the African Cancer Atlas in partnership with Roche | ||
| Yemaachi Biotechnology partnered with BioNTech to advance a novel mRNA-based malaria vaccine project and to accelerate the development of an oncology center of excellence in Africa, combining BioNTech’s expertise in mRNA vaccine development with Yemaachi’s deep understanding of the local landscape and clinical research. | ||
Nice Try Sign up to Ethos to access the full customer list Sign up to Ethos | Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. | Source |
Sign up to Ethos to access the full customer list, plus detailed competitor and product analysis.
Sign up to Ethos